[1] Goodman A. Abnormal genital tract bleeding. Clin Cornerstone, 2000,3:25-35. [2] 刘军,王玲,刘敏,等.肝硬化患者合并非妊娠异常子宫出血的诊断和治疗.中华肝脏病杂志,2011,19:52-54. [3] Fraser IS, Warner P, Marantos PA.Estimating menstrual blood loss in women with normal and excessive mensmtal fluid volume.Obstet Gynecol, 2001, 98: 806-814. [4] Gallinat A, Nugent W. NovaSure impedance-controlled system for endometrial ablation. J Am Assoc Gynecol Laparosc, 2002, 9:279-285. [5] Higham JM, O'Brien PMS, Shaw RW. Assessment of menstrual blood loss using a pictorial chart. Br J Obstet Gynaecol, 1990, 97:734-739. [6] Kaplan DE, Dai F, Aytaman A, et al. Development and performance of an algorithm to estimate the Child-Turcotte-Pugh Score from a national electronic healthcare database. Clin Gastroenterol Hepatol, 2015. 13:2333-2341 [7] Committee on Practice Bulletins—Gynecology. Practice bulletin No. 128: Diagnosis of abnormal uterine bleeding in reproductive-aged women. Obstet Gynecol, 2012;120:197-206. [8] Gimpelson RJ. Ten-year literature review of global endometrial ablation with the NovaSure(R) device. Int J Womens Health, 2014,6:269-280. [9] El-Awadi S, El-Nakeeb A, Youssef T, et al. Laparoscopic versus open cholecystectomyin cirrhotic patients: a prospective randomized study. Int J Surg 2009,7:66-69. [10] Hamad MA, Thabet M, Badawy A, et al. Laparoscopic versus opencholecystectomy in patients with liver cirrhosis: a prospective, randomized study. J Laparoendosc Adv Surg Tech A, 2010,20:405-409. [11] Ji W, Li LT,Wang ZM, et al A randomized controlled trial of laparoscopic versus open cholecystectomy inpatients with cirrhotic portal hypertension. World J Gastroenterol 2005,28:2513-2517. [12] Poulsen TL, Thulstrup AM, Sorensen HT, et al. Appendicectomy and perioperative mortality in patients with livercirrhosis. Br J Surg, 2000,87:1664-1665. [13] Nguyen GC, Correia AJ, Thuluvath PJ. The impact of cirrhosis and portal hypertension on mortality following colorectalsurgery: a nationwide, population-based study. Dis Colon Rectum,2009,5:1367-1374. [14] Jeong SH, Ahn HS, Yoo MW, et al. Increased morbidity rates in patients with heart disease orchronic liver disease following radical gastric surgery. J Surg Oncol 2010,101:200-204. [15] Patrick C.Caitfiona M.NovaSure endometrial ablation:a review of 400 cases.Gynecol Surg,201l,205:1-4. [16] Lukes AS,McBride RJ,Herring AH,et al.Improvedpremenstrual syndrome symptoms after NovaSure endometrialablation.J Minim Invasive Gynecol,201l,18:607-611. [17] Bongers MY,Bourdrez P,Mol BW,et al.Randomised controlledtrial of bipolar radio—frequency endometrial ablation and balloon endometrial ablation.Obstet Gynaecol,2004,10:1095-1102. [18] Asgari Z,Moini A,Samiee H, et al.Endometrial ablation with the Novasure system in Iran. Int J Gynaecol Obstet,2011,114:73-75. [19] Gallos ID1, Yap J, Rajkhowa M, et al.Regression, relapse, and live birth rates with fertility-sparing therapy for endometrial cancer and atypical complex endometrial hyperplasia: a systematic review and metaanalysis.Am J Obstet Gynecol. 2012,207:266.e1-12. [20] Sirimusika N, Peeyananjarassri K, Suphasynth Y, et al. Management and clinical outcomes of endometrial hyperplasia during a 13-year period in Songklanagarind Hospital. J Med Assoc Thai, 2014,97:260-266. [21] Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, andendometrium. Int J Gynaecol Obstet, 2009,105:103-104. [22] Sorosky JI. Endometrial cancer. Obstet Gynecol, 2008,111: 436-447. |